Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: Tomato who wrote (1208)	1/21/2004 2:04:21 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1833

If it feels like 2002 at the end of 2004, KDUS will be among the most respected of biotechs. :-) Talked briefly with Ms. Paige, and then emailed her a ton of (IMO) relevant stuff. No feedback, as I asked that communications be one-way. I fed her all info that I could relative to SLV320, adenosine receptors as target, etc. I tried one theme...... reacquire the OSI program if possible (pharma margins are 90%-plus, some drugs sell at $5B/year, the MC of KDUS is peanuts, yada, yada). I emphasized that biotech companies are worthless without cash or I.P., but that the two are "valuation synergistic". She had lost everything that I sent in that previous round of communications, hard drive crash.